trending Market Intelligence /marketintelligence/en/news-insights/trending/mygTLUPY7MJow4-HPazLLQ2 content esgSubNav
In This List

CytoDyn appoints chief technology officer

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


CytoDyn appoints chief technology officer

CytoDyn Inc. has appointed Nitya Ray as the company's chief technology officer — head of process science, manufacturing and supply chain.

He was most recently executive vice president, head of product development, manufacturing and supply chain of Actinium Pharmaceuticals Inc. In addition, he was a senior vice president of Progenics Pharmaceuticals Inc.

Vancouver, Wash.-based CytoDyn is a biotechnology company developing treatments for HIV.